The Uganda National Drug Authority has put on alert drug inspectors atentry points and intensified surveillance of a controversial AIDS drug, herirontinasiferon, imported from Zambia.
"The Authority has never been contacted nor authorized the importation of such a drug," Deus Mubangisis, the NDA's acting executive secretary, told the New Vision newspaper.
A consignment of the drug worth $1 million was imported late last month into Uganda, a report from Zambia's capital Lusaka said. Zambian professor Mulenga Lukwesa, the drug's inventor, claimed that his patients found the drug effective. However, the Zambian Health Ministry has banned the use and sale of the drug until competent international medical institutions have assessed it.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze